CADTH’s Pharmaceutical Reviews Updates are used to communicate new CDR and pCODR drug review processes updates to the public. PDCI has outlined below the key highlights from the most recent update. For more information on this review, please consult the CADTH’s website. CADTH has three new consultations ... Read More


INESSS has launched a modernized website that is more user-friendly and provides greater transparency. Some of the highlighted new features includes: Enhanced search engine that allows broader searches throughout the full website and that offers additional Advance Search filters. New Social Services, Drugs and Health Services sections which provide new ... Read More


Did you or your organization submit written comments to the recent national pharmacare consultation? If so, PDCI has volunteered to accumulate & share submissions from all stakeholders on a centrally located webpage available here. If you would like your voice added to this important policy discussion, please send ... Read More


***Participation Requested*** Sharing Responses to the National Pharmacare Public Consultation Announced in the 2018 federal budget and chaired by former Ontario Health Minister Eric Hoskins, the Advisory Council on the Implementation of National Pharmacare is currently engaging in a national dialogue on how the federal government could implement ... Read More


Health Canada, CADTH, and Quebec’s Institut national d’excellence en santé et en services sociaux (INESSS) have officially launched efforts to align regulatory and health technology assessment (HTA) drug reviews for eligible submissions, effective immediately. Background The new process stems from Health Canada and HTAs recognizing the need for greater coordination of the ... Read More


On April 27, 2018, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers advising that their submission guide document, submission checklists and various forms and letter templates have been updated effective immediately. For more information, please consult the following link or the ... Read More


Following Question Period this afternoon, the House of Commons Standing Committee on Health released its long-anticipated report on the development of a national pharmacare program in Canada. The report, entitled Pharmacare Now: Prescription Medicine Coverage for All Canadians, is the culmination of two years of evidence considered by the Committee ... Read More


Released yesterday, the Government of Saskatchewan’s 2018-19 budget earmarked a record $5.36B for provincial health initiatives, including $600,000 to provide HIV medications at no cost for eligible Saskatchewan Health beneficiaries. This announcement eliminates cost-sharing deductibles/co-payments that were previously included as part of the province’s coverage of HIV medications. This ... Read More


On April 4, 2018, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers announcing further details on the evaluation process. Pre-NOC Evaluations Manufacturers can submit an application for registration to INESSS for a new innovative drug product, a new biosimilar drug product, a new product ... Read More


This afternoon Federal Finance Minister Bill Morneau unveiled his government’s third budget, focussing on a strong middle class, gender equality, indigenous reconciliation, and – as leaked yesterday upon the resignation of Ontario Health Minister Eric Hoskins – a new Advisory Council on the Implementation of National Pharmacare. According to Budget 2018, ... Read More